Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,728 shares at $420.24 ($1.2M) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Scheduled sale ($1.2M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $422.74 | 2,100 | $888K | 77.1% |
| 2 | $420.24 | 314 | $132K | 11.5% |
| 3 | $420.24 | 314 | $132K | 11.5% |
| Total | $422.16 avg | 2,728 | $1.2M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |